We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
(+13%)
Cap. Flow
+$2.18B
Cap. Flow
% of AUM
18.39%
Top 10 Holdings %
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$34.6M |
| 2 |
Workday
WDAY
|
+$33.5M |
| 3 |
FRC
First Republic Bank
FRC
|
+$31.8M |
| 4 |
Zoetis
ZTS
|
+$31.3M |
| 5 |
Synchrony
SYF
|
+$31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$35.7M |
| 2 |
Honeywell
HON
|
+$31.7M |
| 3 |
International Paper
IP
|
+$30.5M |
| 4 |
Archer Daniels Midland
ADM
|
+$23.8M |
| 5 |
Emerson Electric
EMR
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.12% |
| 2 | Financials | 17.75% |
| 3 | Healthcare | 12.17% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Industrials | 11.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Unifirst Corp
UNF
$5.25B
| $451K | ﹤0.01% |
+2,450
| New | +$453K |
|
|
GRFS
2602
Grifois
GRFS
$5.38B
| $450K | ﹤0.01% |
+38,532
| New | +$443K |
|
2603
Amylyx Pharmaceuticals
AMLX
$2.66B
| $449K | ﹤0.01% |
+34,914
| New | +$789K |
|
|
CCC
2604
CCC Intelligent Solutions
CCC
$4.03B
| $449K | ﹤0.01% |
40,689
-27,917
| -41% | -$293K |
|
2605
Strategy Inc
MSTR
$37.6B
| $449K | ﹤0.01% |
9,230
-9,340
| -50% | -$404K |
|
2606
Ethan Allen Interiors
ETD
$570M
| $448K | ﹤0.01% |
+17,192
| New | +$443K |
|
|
XHR
2607
Xenia Hotels & Resorts
XHR
$1.74B
| $448K | ﹤0.01% |
23,199
-11,363
| -33% | -$208K |
|
|
TTCF
2608
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
| $448K | ﹤0.01% |
35,630
+25,273
| +244% | +$320K |
|
2609
HighPeak Energy
HPK
$937M
| $446K | ﹤0.01% |
+20,102
| New | +$395K |
|
2610
Sana Biotechnology
SANA
$1.14B
| $446K | ﹤0.01% |
53,976
+40,476
| +300% | +$327K |
|
|
DOMA
2611
DELISTED
Doma Holdings, Inc.
DOMA
| $446K | ﹤0.01% |
8,216
+2,674
| +48% | +$215K |
|
2612
Li Auto
LI
$12.3B
| $445K | ﹤0.01% |
17,238
-20,355
| -54% | -$561K |
|
|
CD
2613
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $445K | ﹤0.01% |
70,352
+55,342
| +369% | +$305K |
|
2614
Beazer Homes USA
BZH
$873M
| $442K | ﹤0.01% |
29,025
+506
| +2% | +$8.98K |
|
2615
Myriad Genetics
MYGN
$301M
| $442K | ﹤0.01% |
+17,525
| New | +$448K |
|
|
BGFV
2616
DELISTED
Big 5 Sporting Goods
BGFV
| $441K | ﹤0.01% |
25,740
-10,263
| -29% | -$183K |
|
2617
Tango Therapeutics
TNGX
$4.44B
| $439K | ﹤0.01% |
+57,880
| New | +$502K |
|
2618
OneSpan
OSPN
$600M
| $438K | ﹤0.01% |
+30,319
| New | +$458K |
|
2619
Aurora
AUR
$13.4B
| $435K | ﹤0.01% |
77,797
+8,513
| +12% | +$49K |
|
2620
Accuray
ARAY
$33.4M
| $433K | ﹤0.01% |
130,784
-77,726
| -37% | -$289K |
|
|
TBCH
2621
Turtle Beach Corp
TBCH
$228M
| $433K | ﹤0.01% |
+20,356
| New | +$426K |
|
2622
Helen of Troy
HELE
$695M
| $432K | ﹤0.01% |
2,207
+400
| +22% | +$84.3K |
|
|
CHCT
2623
Community Healthcare Trust
CHCT
$430M
| $431K | ﹤0.01% |
+10,211
| New | +$442K |
|
|
ONT
2624
Onterris Inc
ONT
$575M
| $431K | ﹤0.01% |
8,150
-18,183
| -69% | -$900K |
|
2625
Celldex Therapeutics
CLDX
$3.49B
| $430K | ﹤0.01% |
12,633
-16,353
| -56% | -$523K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q1 2022 Portfolio in Review
As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.
- Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
- Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
- Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
- Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
- Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
- Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
- Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.
Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.